The predominance of A(H3N2) clade 3C.3a viruses during the latter part of the 2018-2019 influenza season was associated with a decrease in vaccine effectiveness, according to results of a new study.

A workshop convened by the National Institutes of Health offers recommendations for new research to improve delivery of preventive services and reduce disparities across 10 preventable conditions.

“Our study demonstrates an opportunity in which a community health-system pharmacy department can use pharmacists and advanced practice nurses to provide services to employees and their spouses who have hypertension or dyslipidemia,” researchers wrote.

Patients receiving opioid analgesics who had multiple prescribers or pharmacies were more likely to receive outpatient sublingual buprenorphine for addiction, according to recent study findings.

“Homeless patients with hypertension and/or type 2 diabetes who had at least one visit with a pharmacist showed some improved health outcomes,” researchers wrote.

Independent experts on an FDA advisory panel were recently split over the approval of a non-opioid painkiller to manage post-surgical pain.

According to WHO, a novel coronavirus is responsible for the outbreak of pneumonia of unknown etiology in Wuhan City, Hubei Province, China, which was initially reported on December 31, 2019, and the first imported case of lab-confirmed infection has been reported in Thailand.

Changes in FDA procedures meant to speed approvals for medications may have resulted in less exacting standards, a new analysis suggests.

Patients with venous thromboembolism (VTE) who take statins may have a significantly lower risk of recurrent VTE, according to a new study.

A New York company that was the first drug distributor to face US felony charges for its role in fueling the opioid crisis said it will stop distributing controlled pharmaceuticals, which include opioids.